Literature DB >> 3339549

Cataracts in Dunedin Program participants: an evaluation of risk factors.

R G Marks1, W E Hale, L L Perkins, F E May, R B Stewart.   

Abstract

A geriatric health screening program in Dunedin, Florida, was used to evaluate risk factors leading to development of cataracts. A total of 2,787 participants completed the fourth yearly visit to the program. At the time of the fourth visit, 49.3% of women (mean age 75.1 years) and 38.2% of men (mean age 75.4 years) reported the presence of cataracts. Age was found to be the most significant risk factor in cataract development (P less than .0001). Both men and women with cataracts had significantly lower serum cholesterol concentrations than subjects without cataracts. After adjusting for age and sex, diazepam (P less than .03), furosemide (P less than .04), isosorbide (P less than .003), and ibuprofen (P less than .03) were found to be positively associated with cataracts; triamterene (P less than .05) had a negative association, indicating a protective relationship. Aspirin was not shown to have a protective effect on reported cataracts.

Entities:  

Mesh:

Year:  1988        PMID: 3339549     DOI: 10.1016/s0886-3350(88)80065-8

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

1.  Community-based study of cataracts among type 2 diabetics in Kinmen.

Authors:  Tao-Hsin Tung; Jorn-Hon Liu; Fenq-Lih Lee; Shih-Jen Chen; Ching-Yao Tsai; Pesus Chou
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Prospective epidemiological cohort study of reduced risk for incident cataract with vigorous physical activity and cardiorespiratory fitness during a 7-year follow-up.

Authors:  Paul T Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-11       Impact factor: 4.799

3.  Association between serum lipids concentration and patients with age-related cataract in China: a cross-sectional, case-control study.

Authors:  Mingxi Shao; Wenjun Cao; Shengjie Li; Danhui Li; Yudong Zhang; Jisen Teng
Journal:  BMJ Open       Date:  2018-04-05       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.